The metastasis of cancer to bone is a frequent outcome of common malig
nancies and is often associated with significant morbidity due to oste
olysis. Bone metastasis is also selective in that a disproportionately
small number of malignancies account for the majority of tumors which
spread to bone. While the mechanisms of bone destruction have been st
udied, those responsible for the site-specific nature of bone metastas
is are poorly understood. As a metastatic target, bone is unique in th
at it is continuously being remodelled under the influence of local an
d systemic growth factors, many of which are embedded in the bone matr
ix. This review summarizes evidence for the hypothesis that the format
ion of metastatic tumors in bone is the consequence of a unique microe
nvironment where metastatic cells can alter the metabolism of bone, th
ereby regulating the release of soluble bone-derived growth factors as
a consequence of bone resorption. These, in turn, can modulate the ma
lignant phenotypic properties of receptive cells. Transforming growth
factor-beta is one factor which can promote the growth and motility of
Walker 256 cells, a rat cell line with a propensity to metastasize sp
ontaneously to bone.